Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Haoyuan Cao"'
Publikováno v:
BMC Cancer, Vol 24, Iss 1, Pp 1-20 (2024)
Abstract Background In the past few decades, researchers have made promising progress, including the development of immune checkpoint inhibitors (ICIs) in the therapy of bladder cancer (BLCA). Existing studies mainly focus on single immune checkpoint
Externí odkaz:
https://doaj.org/article/67050b0680e24a829c04114b4ec650c2
Autor:
Baozhong Yu, Xiang Zheng, Zejia Sun, Peng Cao, Jiandong Zhang, Zihao Gao, Haoyuan Cao, Feilong Zhang, Wei Wang
Publikováno v:
PLoS ONE, Vol 16, Iss 1, p e0245741 (2021)
PurposeAlpha-adrenergic receptor blockers can be effectively used in the context of medical expulsion therapy (MET) to treat ureteric stones. This study was designed to evaluate the safety and efficacy of doxazosin in MET relative to placebo or tamsu
Externí odkaz:
https://doaj.org/article/b13604318d2d4b1fad912c6cb1c86141
Publikováno v:
Technology in Cancer Research & Treatment, Vol 19 (2020)
Background: Disabled homolog 2-interacting protein is a new member of the Ras GTPase superfamily involved in the regulation of cell proliferation, apoptosis, and metastasis. However, the expression of disabled homolog 2-interacting protein in renal c
Externí odkaz:
https://doaj.org/article/6d2aea2f3bb34faba689b0922aa9b01a
Autor:
Chen Zhang, Baozhong Yu, Huawei Cao, Feilong Zhang, Zihao Gao, Jiyuan Wu, Wei Wang, Haoyuan Cao, Xiang Zheng, Zejia Sun, Changzhen Hao, Jiandong Zhang, Peng Cao
Publikováno v:
Aging (Albany NY)
Bladder cancer (BC) is a commonly occurring malignant tumor affecting the urinary tract. Zinc finger proteins (ZNFs) constitute the largest transcription factor family in the human genome and are therefore attractive biomarker candidates for BC progn
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::defe69c6fbcf97886ec35bbcbad35d39
https://doi.org/10.18632/aging.202984
https://doi.org/10.18632/aging.202984
Publikováno v:
Journal of Constructional Steel Research. 198:107554
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6d1c0f4a7b7e44676efdaeb434ff12e7
https://doi.org/10.1016/j.jcsr.2022.107554
https://doi.org/10.1016/j.jcsr.2022.107554
Autor:
Xiang Zheng, Jiandong Zhang, Haoyuan Cao, Peng Cao, Zihao Gao, Baozhong Yu, Zejia Sun, Feilong Zhang, Wei Wang
Background Renal cell carcinoma (RCC) is a common tumor of the urinary system. Nowadays, Immunotherapy is a hot topic in the treatment of solid tumors, especially for those tumors with pre-activated immune state. Methods In this study, we downloaded
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::83489b947a9417b31f3268ab960e1edc
https://doi.org/10.21203/rs.3.rs-41009/v1
https://doi.org/10.21203/rs.3.rs-41009/v1
Publikováno v:
Technology in Cancer Research & Treatment, Vol 19 (2020)
Technology in Cancer Research & Treatment
Technology in Cancer Research & Treatment
Background: Disabled homolog 2-interacting protein is a new member of the Ras GTPase superfamily involved in the regulation of cell proliferation, apoptosis, and metastasis. However, the expression of disabled homolog 2-interacting protein in renal c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d18c146408a6250c23df3d530e7a0c17
https://doaj.org/article/6d2aea2f3bb34faba689b0922aa9b01a
https://doaj.org/article/6d2aea2f3bb34faba689b0922aa9b01a
Autor:
Wei Wang, Xiang Zheng, Zihao Gao, Feilong Zhang, Zejia Sun, Jiandong Zhang, Baozhong Yu, Haoyuan Cao, Peng Cao
Publikováno v:
PLoS ONE, Vol 16, Iss 1, p e0245741 (2021)
PLoS ONE
PLoS ONE
Purpose Alpha-adrenergic receptor blockers can be effectively used in the context of medical expulsion therapy (MET) to treat ureteric stones. This study was designed to evaluate the safety and efficacy of doxazosin in MET relative to placebo or tams
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c5f3142f139339637b1b7b60505a33dd
https://doi.org/10.1371/journal.pone.0245741
https://doi.org/10.1371/journal.pone.0245741
Autor:
Baozhong Yu, Peng Cao, Jiandong Zhang, Feilong Zhang, Wei Wang, Xiang Zheng, Zejia Sun, Haoyuan Cao, Zihao Gao
Publikováno v:
Medicine
Background: Renal cell carcinoma (RCC) accounts for 2% to 3% of all human malignancies and is the 9th most common malignancy in Western countries. Due to the development of surgical procedures and the use of novel drugs, survival has been significant
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bb65197a549ea637ef6a7e6192a6308e
https://doi.org/10.1097/md.0000000000024257
https://doi.org/10.1097/md.0000000000024257